Title
Category
Credits
Event date
Cost
Radiation Oncology Management of Lung Cancer in NC: Update on Small-Cell Lung Cancer
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Ashley Weiner, MD, PhD, presents on the role of radiotherapy for small-cell lung cancer. She provides overview of radiation oncology, and a walk through a patient's pathway from initial consultation with a radiation oncologist to treatment and follow-up. Finally, she reviews the indications for, logistics of, and side effects of radiation for the treatment of small cell lung cancer (limited and extensive stage).
The Ketogenic Diet for Brain Tumor Patients: A Phase 1 Trial and Beyond...
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Jethro Hu, MD, will review the rationale and current evidence supporting the potential role of a ketogenic diet for brain tumor patients, focusing on a recently completed phase 1 safety and feasibility trial.
Clinical Updates in Breast Oncology - SPOC
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Innovations in breast oncology can translate to improved patient outcomes for patients with early and late-stage disease. In this webinar, Dr. Ray will discuss the latest research findings and how they can be translated into the clinical care of patients with breast cancer.
Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC): An Evolving Diagnostic and Therapeutic Paradigm
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 CTR Category A
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Joshua F. Zeidner, MD, will discuss the evolving diagnostic algorithm for AML-MRC, prognosis, treatment outcomes, and unmet needs.
Cardiovascular Toxicities of Cancer Therapies
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Brian Colwell Jensen, MD, will introduce the audience to potential cardiovascular adverse effects of contemporary cancer therapeutics.
Genitourinary Cancer Management in North Carolina
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.25 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Hung-Jui Tan, MD, MSHPM, will review recent practice-changing research and new management recommendations for patients with prostate, kidney, bladder, and testicular cancer.
Lymphoma Management in North Carolina: Updates for 2023
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR Category A
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Natalie Grover, MD, will review some of the recent advances in the treatment of lymphoma, including the incorporation of novel targeted agents in the frontline treatment of diffuse large B cell lymphoma and Hodgkin lymphoma, the use of CAR-T cell therapy in second-line treatment in diffuse large B cell lymphoma, and recently approved drugs by the FDA for lymphoma.
Caring for Older Adults with Acute Leukemia in North Carolina
  • Research to Practice
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Daniel Richardson, MD, MA, MSc, will explore best practices to approach the care of older adults with leukemia. He will also discuss novel therapeutic options for patients with acute lymphoblastic and acute myeloid leukemia alongside practical considerations to approach shared decision-making.
Partnership for Native American Cancer Prevention
  • Southeastern American Indian Cancer Health Equity Partnership
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
In working to address Native American cancer health disparities, it is imperative to build partnerships with tribal communities to increase their trust in the potential benefits of cancer research efforts. The Partnership for Native American Cancer Prevention was established in 2002 and the Partnership’s approach is to expand capacity for culturally-sensitive and community-relevant research on cancer and to continue to develop respectful collaborations that empower sovereign Native American communities to define, implement, and achieve their goals for cancer health equity.
Closing the Chasm Between Native Community Priorities in Cancer Prevention and Healthcare Research Priorities - SPOC
  • Advanced Practice Provider
  • 1.00 Participation
$0.00
Cancer touches all of our lives. For many Native communities, fears of cancer risk from environmental sources beyond their control are common. Some researchers, usually unaware of Native community concerns, can harbor the perspective that Native communities could be fruitful populations for studying the genetic risks of cancer. This webinar will help both sides of this chasm understand the other's point of view, hopefully leading to more effective communications and priority setting.

Pages